ELLISON TIMMER: Open Payments
NPI 1982976304 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 24 payments from 11 companies in 2025. Trend: 2023 $889 · 2024 $688 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| PFIZER INC. | 3 | $67 |
| Gilead Sciences, Inc. | 3 | $67 |
| SpringWorks Therapeutics, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Exelixis Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: TECVAYLI, PLUVICTO, Trodelvy, OGSIVEO, OJJAARA, OPDIVO, PADCEV, BLENREP.
Industry payments across MI — which companies pay providers there.
